Diabetes care today: Not everyone should have intensive multipharmacological treatment

Scandinavian Journal of Primary Health Care

Volumn 22, Issue 2, 2004, Pages 67-70

  Olivarius, Niels De Fine ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

General practice; Goal setting; Risk assessment; Type 2 diabetes mellitus

Indexed keywords

GENERAL PRACTICE; HUMAN; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; TREATMENT INDICATION; TREATMENT PLANNING;

ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; DENMARK; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; HUMANS; HYPOGLYCEMIC AGENTS; RISK FACTORS;

EID: 3042628666     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/02813430410005874     Document Type: Review

References (17)

1. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study Group. Lancet 1998;352:837-53.
2. UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13.
3. Gæde P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999;353:617-22.
4. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997;20:614-20.
5. Tuomilehto J. Controlling glucose and blood pressure in type 2 diabetes. BMJ 2000;321:394-5.
6. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
7. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321:412-9.
8. Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization. JAMA 1997;278:1663-9.
9. Olivarius NdeF, Beck-Nielsen H, Andreasen AH, Horder M, Pedersen PA. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ 2001;323:970-5.
10. Hansen LJ, Olivarius NdeF, Siersma V, Beck-Nielsen H, Pedersen PA. Encouraging structured personalised diabetes care in general practice. A 6-year follow-up study of process and patient outcomes in newly diagnosed patients. Scand J Prim Health Care 2003;21:89-95.
11. Dødsårsagerne 1996. Del 1. [Causes of Death in Denmark 1996. Part 1]. Copenhagen: The National Board of Health, 1998.
12. Centers for Disease Control and Prevention. National Center for Health Statistics. GMWKI_96. http://www.cdc.gov/nchs/data/statab/gmwki_96.pdf
13. Van der Does FE, De Neeling JN, Snoek FJ, Kostense PJ, Grootenhuis PA, Bouter LM, et al. Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care 1996;19:204-10.
14. Sclar DA, Robison LM, Skaer TL, Dickson WM, Kozma CM, Reeder CE. Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race. Diabetes Educ 1999;25:531-8.
15. Osler M, Schroll M. Lifestyle and prevention of ischaemic heart disease in Denmark. Changes in knowledge and behaviour 1982-1992. Eur J Publ Health 1995;5:109-12.
16. Olivarius NdeF, Andreasen AH. 5-Year all-cause mortality of 1323 newly diagnosed middle-aged and elderly diabetic patients. Data from the population-based study, "Diabetes Care in General Practice", Denmark. J Diab Comp 1997;11:83-9.
17. Hansen LJ, Olivarius NdeF, Siersma V, Drivsholm T, Andersen JS. Individualised treatment goals in diabetes care. Scand J Prim Health Care 2004;22:71-77.